Gelteq announced today that it received a U.S. patent for its GTT Gel product for testing human response to oral glucose loads. Melbourne, Australia-based Gelteq designed its GTT Gel diabetes diagnostic system for use in pathology labs and at-home testing through a proprietary gel-based delivery system. The tests take blood samples from patients at different […]
